跳至主要内容
临床试验/PACTR202404654347323
PACTR202404654347323尚未招募Unknown

Evaluation of the Immunogenicity of Concomitant Administration of Novel Oral Polio Type 2 Vaccine (nOPV2) with Sabin OPV in Children aged 6 - 59 months in Mozambique

World Health Organization0 个研究点目标入组 888 人开始时间: 2024年2月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
888

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • ?Healthy child aged 6-59 months old
  • ?Resident in study area for the duration of the study period
  • ?Parent/guardian consent for participation in the study
  • ?Child included in nOPV2 study or their brothers, cousins, neighbour children

排除标准

  • ?Health issue contraindication for venepuncture
  • ?Acutely sick child or child requiring hospitalization.
  • ?Diagnosis or suspicion of congenital immunodeficiency disorder in the subject or an immediate family member

研究者

相似试验

已完成
不适用
Safety, efficacy and immunogenicity of concomitant molecular target drug or cytokine therapy and autologous tumor lysate-pulsed dendritic cell therapy in patients with advanced renal cell carcinomaRenal cell carcinoma
JPRN-UMIN000014703The University of Tokyo Hospital15
已完成
不适用
Safety, efficacy and immunogenicity of concomitant interferon alpha and autologous tumor lysate-pulsed dendritic cell therapy in patients with advanced renal cell carcinomaRenal cell carcinoma
JPRN-UMIN000006646The University of Tokyo Hospital15
进行中(未招募)
1 期
Concomitant administration of the Novavax vaccine and a 20-valent pneumococcal conjugate vaccine in adults aged =60 yearsVaccination is a key strategy for preventing respiratory illnesses. Pneumococcal vaccination is recommended for all adults (age >60 years). Given their wide application, co-administration of pneumococcal and Covid-19 vaccines may support broad population-wide coverage. However, it is unclear whether the co-administration of the new, Omicron-adapted Novavax (NVX XBB.1.5) vaccine and a 20-valent pneumococcal conjugate vaccine results in lower immunogenicity than the administration of either alone.
EUCTR2022-004118-12-ATMedical University of Vienna256
已完成
4 期
Immunogenicity and safety of the simultaneous administration of MR and yellow fever vaccines among Japanese adultsYellow fever, Measles and Rubella
JPRN-UMIN000042738Tokyo Medical University Hospital Travellers' Medical Center14
招募中
4 期
Immunogenicity and safety of the simultaneous administration of MR and yellow fever vaccines among Japanese adultsPrevention of Yellow fever, Measles and RubellaYellow fever, Measles, Rubella
JPRN-jRCT1031210111FUKUSHIMA SHINJI20